%D9%83%D8%A7%D8%A8%D8%B3%D9%8A%D8%AA%D8%A7%D8%A8%D9%8A%D9%86%DA%A9%D9%BE%D8%B3%DB%8C%D8%AA%D8%A7%D8%A8%DB%8C%D9%86Category:CapecitabineCapecitabinCapecitabinCapecitabineCapecitabina%DA%A9%D9%BE%D8%B3%DB%8C%D8%AA%D8%A7%D8%A8%DB%8C%D9%86KapesitabiiniCap%C3%A9citabineKapecitabin%D4%BF%D5%A1%D5%BA%D5%A5%D6%81%D5%AB%D5%BF%D5%A1%D5%A2%D5%AB%D5%B6KapesitabinCapecitabina%E3%82%AB%E3%83%9A%E3%82%B7%E3%82%BF%E3%83%93%E3%83%B3Capecitabine%E0%AC%95%E0%AC%BE%E0%AC%AA%E0%AD%87%E0%AC%B8%E0%AC%BE%E0%AC%87%E0%AC%9F%E0%AC%BE%E0%AC%AC%E0%AC%BF%E0%AC%A8KapecytabinaCapecitabinaCapecitabin%C4%83%D0%9A%D0%B0%D0%BF%D0%B5%D1%86%D0%B8%D1%82%D0%B0%D0%B1%D0%B8%D0%BDKapecitabinKapecitabinKapecitabin%D0%9A%D0%B0%D0%BF%D0%B5%D1%86%D0%B8%D1%82%D0%B0%D0%B1%D1%96%D0%BDCapecitabineQ420207
about
sameAs
large intestine cancerbreast cancerinvasive mammary ductal carcinomagastrointestinal carcinomaampulla of Vater cancerrectum adenocarcinomacolon cancercolon adenocarcinomarectosigmoid cancergastric adenocarcinomapancreatic adenocarcinomabile duct carcinomasmall intestine carcinomaanal carcinomarectum cancerappendix cancercarcinoma of gallbladder and extrahepatic biliary tract
P2176
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaEfficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerCapecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 TumoursANG1005 in Leptomeningeal Disease From Breast CancerA Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaThe Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric CancerXELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric AdenocarcinomaEvaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric CancerBiological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal CancerPhase II Study of Preoperative Chemoradiotherapy With Capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal CancerDose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerPreoperative Radiotherapy and E7046 in Rectum CancerEpirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast CancerA Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerCombination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerDose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaSafety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaCO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaGemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryPhase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerGemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanCapecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCapecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast CancerClinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerPyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With CancerA Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal CancerInvestigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorA Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal CancerPhase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerVinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerChemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerRandomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast CancerCapecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal CancerBevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStudy of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal CancerLarotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing RegimenCapecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
P4844
Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer PatientsPhase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocolA remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two casesRare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case ReportCost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspectiveCapecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority TrialComparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabineCo-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer TreatmentConcomitant Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
P921
Q12048781-13C2A06B-F66B-45C8-89C3-F8A87F6FF23FQ128581-D4472AD2-F6EF-4F9D-A0AE-E83039949DA7Q1671685-A1BC1A05-CD6B-461E-B068-092F4193849CQ18553565-45A34475-7D5A-4CEE-B725-5E8F25347B4FQ18553760-D0633130-43DF-4C78-B674-6B37D0914BD7Q18554959-F96B0519-AE32-4576-9336-863A16170F94Q18555025-22230C6B-8D95-4B74-A4BB-B9B5F6E91522Q18555055-2E6FCFFE-A744-42BA-8431-DCB400353B28Q18555196-590AECFD-C0BF-4C27-82B8-BC7710FAC43CQ18556047-2E0398F3-22CB-4E9D-B14C-38E257989BA8Q18556189-AFC9A872-238C-43BB-B76F-B882A17C1F9CQ18556531-4D6ECE7B-13AD-42C3-9332-44D2050CF544Q18556538-529F4D3F-8136-4A00-9343-A683FD6BDC3DQ18556540-868E8541-995D-4944-B710-4B8518399C55Q2739660-4ECB49EE-44E9-4482-8FD2-E5FE093B0937Q4781026-A19D6531-F730-47BA-AFFD-CDD0F11DFAB0Q56014224-09DF77BE-1BFA-4BAE-9ABB-498317A6A4A5
P2176
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Capecitabin
@de
Capecitabina
@es
Capecitabine
@nl
Capecitabină
@ro
Kapecitabin
@hr
Kapecitabin
@sh
Kapecitabin
@sl
Kapecitabin
@sr
Kapesitabin
@id
capecitabin
@cy
type
label
Capecitabin
@de
Capecitabina
@es
Capecitabine
@nl
Capecitabină
@ro
Kapecitabin
@hr
Kapecitabin
@sh
Kapecitabin
@sl
Kapecitabin
@sr
Kapesitabin
@id
capecitabin
@cy
altLabel
(1-(5-Deoxy-beta-D-ribofuranos ...... yl)-carbamic acid pentyl ester
@cy
(1-(5-Deoxy-beta-D-ribofuranos ...... yl)-carbamic acid pentyl ester
@en
154361-50-9
@fr
C15H22FN3O6
@fr
Capecitabin
@en
Capecitabina
@en
Capecitabine
@de
Capecitabine
@en
Capecitabine
@fr
Capecitabinum
@en
prefLabel
Capecitabin
@de
Capecitabina
@es
Capecitabine
@nl
Capecitabină
@ro
Kapecitabin
@hr
Kapecitabin
@sh
Kapecitabin
@sl
Kapecitabin
@sr
Kapesitabin
@id
capecitabin
@cy